Work

Markers of angiogenesis and hypoxia to cell of origin (COO) subtypes of DLBCL: Correlative studies from S0515, a phase II trial of R-CHOP plus bevacizumab.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.8562

Authors: Ambuga R. Badari, Mohammad Abu Zaid, Joseph M. Unger, Lisa M. Rimsza, Marilyn Marron, Richard I. Fisher, Thomas P. Miller, Alison Stopeck

Institutions: University of Arizona Cancer Center, University of Arizona, University of Rochester

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601418474

Cites:

Cited by:

Related to: 10